These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 37036199)
1. Letter to the Editor: Progressive cholestasis and associated sclerosing cholangitis are complications of COVID-19 in patients with chronic liver disease. Umar S; Nadeem A; Nadeem M Hepatology; 2023 Jul; 78(1):E14-E15. PubMed ID: 37036199 [No Abstract] [Full Text] [Related]
2. Reply: Progressive cholestasis and associated sclerosing cholangitis are complications of COVID-19 in patients with chronic liver disease. Hartl L; Reiberger T; Trauner M Hepatology; 2023 Jul; 78(1):E16-E17. PubMed ID: 37036261 [No Abstract] [Full Text] [Related]
3. Progressive cholestasis and associated sclerosing cholangitis are frequent complications of COVID-19 in patients with chronic liver disease. Hartl L; Haslinger K; Angerer M; Semmler G; Schneeweiss-Gleixner M; Jachs M; Simbrunner B; Bauer DJM; Eigenbauer E; Strassl R; Breuer M; Kimberger O; Laxar D; Lampichler K; Halilbasic E; Stättermayer AF; Ba-Ssalamah A; Mandorfer M; Scheiner B; Reiberger T; Trauner M Hepatology; 2022 Dec; 76(6):1563-1575. PubMed ID: 35596929 [TBL] [Abstract][Full Text] [Related]
11. Bone involvement in patients with chronic cholestasis. Le Gars L Joint Bone Spine; 2002 Jun; 69(4):373-8. PubMed ID: 12184433 [TBL] [Abstract][Full Text] [Related]
12. Inflammatory pseudotumor of the liver in a patient with chronic sclerosing cholangitis. Gough J; Chakrabarti S Am J Gastroenterol; 1993 Sep; 88(9):1452-3. PubMed ID: 8362850 [TBL] [Abstract][Full Text] [Related]
14. Biliary strictures in hepatic transplants: prevalence and types in patients with primary sclerosing cholangitis vs those with other liver diseases. Sheng R; Zajko AB; Campbell WL; Abu-Elmagd K AJR Am J Roentgenol; 1993 Aug; 161(2):297-300. PubMed ID: 8333366 [TBL] [Abstract][Full Text] [Related]
15. Secondary sclerosing cholangitis as cause of persistent jaundice in patients with severe COVID-19. Bütikofer S; Lenggenhager D; Wendel Garcia PD; Maggio EM; Haberecker M; Reiner CS; Brüllmann G; Buehler PK; Gubler C; Müllhaupt B; Jüngst C; Morell B Liver Int; 2021 Oct; 41(10):2404-2417. PubMed ID: 34018314 [TBL] [Abstract][Full Text] [Related]
16. Endoscopic treatment of biliary tract strictures in sclerosing cholangitis: a larger series and recommendations for treatment. Johnson GK; Geenen JE; Venu RP; Schmalz MJ; Hogan WJ Gastrointest Endosc; 1991; 37(1):38-43. PubMed ID: 2004682 [TBL] [Abstract][Full Text] [Related]
17. Cholestasis in patients with acquired immunodeficiency syndrome: a surgeon's perspective. Liu KJ; Atten MJ; Donahue PE Am Surg; 1997 Jun; 63(6):519-24. PubMed ID: 9168766 [TBL] [Abstract][Full Text] [Related]
18. Azithromycin may reduce cholestasis in primary sclerosing cholangitis: a case report and serendipitous observation. Boner AL; Peroni D; Bodini A; Delaini G; Piacentini G Int J Immunopathol Pharmacol; 2007; 20(4):847-9. PubMed ID: 18179759 [TBL] [Abstract][Full Text] [Related]
19. Rare case of severe cholangiopathy following critical illness. Patel KV; Zaman S; Chang F; Wilkinson M BMJ Case Rep; 2014 Sep; 2014():. PubMed ID: 25270153 [TBL] [Abstract][Full Text] [Related]
20. Prevotella copri ameliorates cholestasis and liver fibrosis in primary sclerosing cholangitis by enhancing the FXR signalling pathway. Jiang B; Yuan G; Wu J; Wu Q; Li L; Jiang P Biochim Biophys Acta Mol Basis Dis; 2022 Mar; 1868(3):166320. PubMed ID: 34896545 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]